aspirin has been researched along with 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, TF; Ko, FN; Teng, CM; Wu, CC | 1 |
Ciampa, MT; Favilla, M; Gazzaniga, PP; Pignatelli, P; Pulcinelli, FM; Riondino, S | 1 |
Berkels, R; Grosser, N; Gründemann, D; Schömig, E; Schröder, H; Taubert, D | 1 |
3 other study(ies) available for aspirin and 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid
Article | Year |
---|---|
Mechanisms-regulated platelet spreading after initial platelet contact with collagen.
Topics: Animals; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Cattle; Collagen; Cytochalasin B; Egtazic Acid; Humans; Oligopeptides; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Signal Transduction | 1996 |
Concomitant activation of Gi protein-coupled receptor and protein kinase C or phospholipase C is required for platelet aggregation.
Topics: Adenosine Diphosphate; Aspirin; Chelating Agents; Crotalid Venoms; Egtazic Acid; Enzyme Activation; Epinephrine; GTP-Binding Proteins; Humans; Indoles; Lectins, C-Type; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1999 |
Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cells, Cultured; Chelating Agents; Citrulline; Coronary Vessels; Egtazic Acid; Endothelium, Vascular; Free Radical Scavengers; Homeostasis; Humans; In Vitro Techniques; Nitric Oxide; Oxidants; Substance P; Superoxides; Swine | 2004 |